Yongke Chen
Key Laboratory Of Drug Targeting And Drug Delivery System Of The Education Ministry And Sichuan Province
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Engineered microglial membrane-coated polydopamine-based nanomedicine for precise treatment of Alzheimer's disease.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 12, 2025
Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy.
Journal: Acta pharmaceutica Sinica. B
Published: January 14, 2025
A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 07, 2024
Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease.
Journal: Acta pharmaceutica Sinica. B
Published: September 22, 2024
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 25, 2023
Cross-Coupling of Cyclobutenone N-Tosylhydrazones with Organohalides: Access to Conjugated Enynes and Enallenes via a Strained Allylpalladium Intermediate.
Journal: Organic letters
Published: December 08, 2022
Palladium-Catalyzed Carbene Coupling Reactions of Cyclobutanone N-Sulfonylhydrazones.
Journal: Organic letters
Published: October 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026